Menu

Prescribing guidelines

Loading…

Clinical support by body system

Conditions and indicators

Alcohol dependence1
Allergic rhinitis1
Angina pectoris1
Antiplatelets1
Asthma2
Atrial fibrillation1
Cancer : Palliative care1
Depression2
Dysphagia1
Epilepsy3
Heart failure4
Incontinence2
Inflammatory Bowel Disease1
Neuropathic pain1
Obesity and bariatric surgery1
Osteoporosis2
Pain management6
Peptic ulcers1
Rheumatoid arthritis1
Stroke2
Substance dependence1
Transient Ischaemic Attack TIA1
Type 1 Diabetes2
Type 2 Diabetes2

Traffic light

April 2022 - APC Approved list of guideline review date extensions (to 3 years from date approved)

First
Back
9
10
11
12
13
14
15
16
Next
Last

Meds: Antimicrobial prescribing guidance summary - managing common infections

Brain and mental health Dermatology, MSK and Rheumatology Gastroenterology Laboratory investigations and Infections Ophthalmology and ENT Paediatrics Renal, Urology and Mens Health Women's and Sexual Health
Meds: Appropriate Use of Monitored Dosage Systems (IMOC Approved)
Meds: Care Homes: Management of Medicines

Cancer, Palliative Care, Pain and Older People
Meds: Domiciliary Care: Medication Guidelines

Cancer, Palliative Care, Pain and Older People
Meds: Drugs to be prescribed by brand
Meds: Linezolid Prescribing Guidance

Dermatology, MSK and Rheumatology Laboratory investigations and Infections Respiratory and Smoking
Meds: Prednisolone - Use Plain not EC tablets - QIPP detail aid (APC approved)

Gastroenterology
Meds: Self Care
Meds: Soluble Prednisolone QIPP detail aid (APC approved)
Meds: Substance Misuse: Special considerations for Oral Nutritional Supplements

Brain and mental health

Substance Misusers and Oral Nutritional Supplements

First
Back
9
10
11
12
13
14
15
16
Next
Last

Did you find this page helpful?